Indications/Contraindications
Surgical débridement for articular cartilage lesions dates back to the early 1940s. The technique of cartilage débridement was initially utilized to address the pain and mechanical symptoms secondary to osteoarthritis (
34). With the advent of arthroscopy and evolution of minimally invasive surgery, arthroscopic débridement became popular as a technically easy and efficient method to treat articular cartilage lesions and arthritic knees. Using high-speed arthroscopic rotary shavers, handheld basket punches, arthroscopic curettes, and RF ablative devices, the procedure consists primarily of the removal of incongruent, unstable cartilaginous flaps, the shaving of fibrillated tissue, the removal of all loose bodies, and the resection of any unstable meniscal tears.
The use of RF devices has been described as an alternative to the mechanical shaving of chondral lesions. Studies have shown that mechanical débridement may result in perimeter irregularities and incomplete resection, which often lead to the damage or removal of healthy articular cartilage, while arthroscopic RF ablation produces smooth edges. However, clinical and basic science studies determining superiority of one débridement method versus the other have been inconclusive. Turner et al. conducted an in vivo study comparing the effects of a bipolar RF probe and a mechanical shaver on roughened articular cartilage in ovine knees. Those in the bipolar-treated group graded better with respect to histologic appearance and showed no evidence of subchondral necrosis (
59). Similarly, in an explant study of human arthritic cartilage, the authors reported that RF devices create a smooth articular surface with no histologic alterations (
27). Amiel et al. (
3) further assessed the viability of chondrocytes ex vivo after treatment with RF and concluded that there was a relatively insignificant margin of chondrocyte death (100 to 200 μm), which did not approach the subchondral bone in any sample. However, in contrast, other studies have shown large margins of chondrocyte death. Lu et al. (
33) reported up to 1mm of cell death in bovine cartilage treated with RF, using confocal laser microscopy, suggesting that previous histologic evaluations underestimated the depth of cell death. Similarly, an experiment on explanted human cartilage resulted in chondrocyte death extending to subchondral bone (
13).
Several clinical studies have compared mechanical shaving to RF débridement. Owens et al. showed superior results with RF treatment of grades 2 and 3 chondral lesions compared with mechanical shaving (
45). More recently, Barber et al. reported no subchondral bone damage or avascular necrosis, and significant clinical improvement in both groups when comparing the effects of monopolar RF and mechanical chondroplasty techniques on grade 3 femoral condyle lesions (
4). While RF devices may have a role as an alternative method for chondroplasty, their superiority over mechanical shaving has yet to result in widespread acceptance, and clinical outcome comparisons have, thus far, been limited.
For appropriately indicated patients, arthroscopic débridement has been shown to produce early satisfactory outcomes in 50% to 90% of patients (
1,
21,
24). Hubbard studied débridement versus lavage in 76 patients with a focal, degenerative grade 3 or 4 femoral condyle lesion, with no concomitant intra-articular pathology, joint deformity, or abnormal radiographs. He reported pain relief in 80% and 65% of patients in the débridement group at 1 and 5 years, respectively, compared with 20% and 11% for those patients who only received an arthroscopic lavage (
21). Other satisfactory results have been seen in patients with symptoms <1 year, a specific history of trauma, and a low BMI (
25).
In an effort to further establish and refine the indications for arthroscopic débridement and lavage for osteoarthritis, Aaron et al. noted that 90% of knees with mild arthritis experienced symptomatic relief, while only 25% with severe arthritis improved (
1). Jackson and Dieterich (
24) found, in a 4 to 6 year retrospective case series of 121 patients treated with arthroscopic débridement, more successful results in patients with earlier stages of arthritis. In a retrospective review of 204 knees with osteoarthritis, Harwin (
19) reported on predictors of patient satisfaction following arthroscopic débridement and noted that those knees with minimal malalignment, no prior surgeries, and a low BMI had better results.
Despite the conclusions of these earlier nonrandomized, noncontrolled case series, recent investigators have found no benefit to arthroscopic joint débridement for arthritis without specific mechanical symptoms. In 2002, Moseley et al. performed a level 1 randomized controlled trial of 180 patients with osteoarthritis who failed medical management, comparing arthroscopic débridement, lavage alone, and placebo “sham” surgery. The results were similar in all three groups, with no surgical benefit proven (
42). More recently, Kirkley et al. conducted a level 1 randomized controlled study of 188 patients treated with either arthroscopic débridement and lavage or physical therapy and medical management. Again, no significant improvement was realized in the surgical group (
28).
In order to better define the indications for arthroscopic débridement of the symptomatic osteoarthritic knee, the American Academy of Orthopaedic Surgery convened a multidisciplinary expert panel to review the
body of literature and, as of December of 2008, established a set of guidelines for arthroscopic débridement for osteoarthritis. The guidelines recommend against performing an arthroscopic lavage, or débridement and lavage, for patients with a primary diagnosis of osteoarthritis but do state that arthroscopic débridement is indicated for those patients with a symptomatic torn meniscus and/or mechanical symptoms of a loose body and associated, underlying osteoarthritis (
58). Furthermore, it should be noted that many focal lesions associated with traumatic etiologies or osteochondritis dissecans (OCD) may have associated perimeter nonviable pathologic chondral tissue that may require adjuvant débridement in association with a resurfacing procedure.
Arthroscopic débridement remains a potentially clinically useful, technically simple palliative treatment for focal, small chondral lesions, with minimal morbidity and few complications. The benefits, however, must be based upon the removal of mechanically unstable tissue, as well as the possible prevention of lesion propagation by débridement of flaps and blisters. The indications for the procedure include those symptomatic patients with well-aligned knees presenting with focal articular cartilage lesions (<1 cm) and lesions with associated flaps or loose bodies, including those associated with OCD or fractures, as well as unstable meniscal tears. Contraindications include diffusely arthritic knees, BMI > 25 to 30, underlying instability, rheumatologic and systemic disorders, sepsis, and joint malalignment.